La Jolla, CA, United States of America

Kyle Jones

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Oxford Finance LLC. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kyle Jones. Retrieved from https://idiyas.com/inventor/kyle-jones-zzrwlieb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations by Inventor Kyle Jones

Introduction

Kyle Jones is an accomplished inventor based in La Jolla, California. He has made significant contributions to the field of immunotherapy, particularly with his innovative work on targeted therapies.

Latest Patents

Kyle holds a patent for "CD33 Targeted Immunotherapies." This patent represents a crucial advancement in the treatment of certain diseases, showcasing his dedication to improving healthcare through innovative solutions. He has 1 patent to his name.

Career Highlights

Kyle is currently employed at Oxford Finance LLC, where he continues to develop and refine his ideas. His work at this company allows him to collaborate with other professionals in the field, further enhancing his contributions to medical science.

Collaborations

Kyle has worked alongside William S. Crago, a fellow innovator. Their collaboration has likely fostered a creative environment that encourages the development of groundbreaking ideas.

Conclusion

Kyle Jones exemplifies the spirit of innovation in the field of immunotherapy. His work not only highlights his individual talent but also contributes to the broader landscape of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…